Officer/Director Liability for Violations of the US Federal Food, Drug, and Cosmetic Act

Officers and directors of Irish and Northern Irish companies whose products would be regulated by the US Food and Drug Administration (life sciences companies, specifically) should be aware of developments on the issue of individual prosecution under the FDCA for company violations of that statute.  AGG partner Alan Minsk and associate Alex Foster have written an update that is new to AGG’s Knowledge Center. Continue reading

Protecting Your Trade Secrets in the US

Remember earlier posts about non-disclosure agreements, and the role they play in defining and protecting trade secrets? Of course you do—but in case you don’t, one of them is here. I even drafted a brief two-page outline for NDAs, here.

The macro point of those posts, at least as to protecting trade secrets, is that in the US, a trade secrets owner must take all “reasonably available steps” to protect their trade secrets. In an unpublished opinion filed on May 8, 2015, the US Court of Continue reading

Selling to the US Government: A Brief Guide for Irish and NI Companies

Irish and Northern Irish companies expanding to the US market should consider selling to the US government as part of their expansion strategy. Last year, the US government purchased almost $500 billion in products and services—it is the single largest customer in the world and it pays its bills. By law, the US government publishes its formal solicitations for purchases valued at more than $25,000 on http://www.fedbizopps.gov. An Irish/Northern Irish company can customize its search for opportunities to sell its products and services to US government. Continue reading